title: Pathophysiology of septic shock: From bench to bedside.
abstract: Our understanding of sepsis and its resultant outcomes remains a paradox. On the one hand, we know more about the pathophysiology of sepsis than ever before. However, this knowledge has not been successfully translated to the bedside, as the vast majority of clinical trials for sepsis have been negative. Yet even in the general absence of positive clinical trials, mortality from sepsis has fallen to its lowest point in history, in large part due to educational campaigns that stress timely antibiotics and hemodynamic support. While additional improvements in outcome will assuredly result from further compliance with evidence based practices, a deeper understanding of the science that underlies the host response in sepsis is critical to the development of novel therapeutics. In this review, we outline immunopathologic abnormalities in sepsis, and then look at potential approaches to therapeutically modulate them. Ultimately, an understanding of the science underlying sepsis should allow the critical care community to utilize precision medicine to combat this devastating disease on an individual basis leading to improved outcomes.
authors.affiliation: Emory University School of Medicine, Emory Critical Care Center, Department of Surgery, Atlanta, GA, United States.
authors.forename: Kevin W
authors.initials: KW
authors.lastname: McConnell
authors.affiliation: Emory University School of Medicine, Emory Critical Care Center, Department of Surgery, Atlanta, GA, United States. Electronic address: cmcoop3@emory.edu.
authors.forename: Craig M
authors.initials: CM
authors.lastname: Coopersmith
mesh_terms: D006801:Humans; D012772:Shock, Septic / Q000276:immunology / Q000503:physiopathology*